Baijal Rajiv, Amarapurkar Deepak, Praveen Kumar H R, Kulkarni Sandeep, Shah Nimish, Doshi Soham, Gupta Deepak, Jain Mayank, Patel Nikhil, Kamani Praful, Issar S K, Dharod Mrudul, Shah Apoorva, Chandnani Madhuri, Gautam Sonali
Department of Gastroenterology, Jagjivan Ram Hospital, Maratha Mandir Marg, Mumbai Central, Mumbai, 400 008, India.
Indian J Gastroenterol. 2014 Jul;33(4):336-42. doi: 10.1007/s12664-014-0461-3. Epub 2014 Jun 1.
Infections are a common and serious complication among patients with cirrhosis. We assessed the epidemiology, risk factors, and clinical consequences of bacterial infections in cirrhotic patients.
In this multicenter prospective study, all patients with cirrhosis of liver with different infections were analyzed. Infections were classified as community-acquired (CA), healthcare-associated (HCA), or hospital-acquired (HA). Site of infection and characteristics of bacteria were recorded; effect on liver function and 30-day survival were evaluated.
One hundred and six out of 420 (25 %) patients with cirrhosis of liver had infection. Infection rate among indoor patients was 37.5 % (92/245) and among outdoor patients was 8 % (14/175). Out of 106 patients, CA, HCA, and HA were seen in 19.8 %, 50 %, and 30.2 %, respectively. Spontaneous bacterial peritonitis (31.1 %), urinary tract infections (22.6 %), and pneumonia and cellulitis (11.3 % each) were common infections. Gram-negative bacteria (54 %) were more common than Gram-positive cocci (46 %). Multidrug resistant (MDR) organisms were seen in 41.7 % of patients. Most of the MDR organisms were seen in HCA and HA patients. The degree of liver impairment was significantly more severe in patients with infection. Independent predictor of infection was high Child-Turcott-Pugh (CTP) class (p = 0.006, Child B vs. A (odds ratio (OR) 3.04 95 % CI = 1.63 to 5.68) and Child C vs. A (OR 4.17 95 % CI = 2.12 to 8.19). Overall in-hospital mortality was 7.6 %. Patients with infection had increased mortality at 30-day follow up compared to those without infection (23.5 % vs. 2.2 %; p<0.001).
Infections are one of the important causes of morbidity and mortality in patients with cirrhosis of liver. The most frequent infections are HCA and HA. Infection predisposes to deterioration of liver function and increases mortality. Cirrhotic patients should be monitored closely for infections especially those with Child class B and C.
感染是肝硬化患者常见且严重的并发症。我们评估了肝硬化患者细菌感染的流行病学、危险因素及临床后果。
在这项多中心前瞻性研究中,对所有患有不同感染的肝硬化患者进行了分析。感染分为社区获得性(CA)、医疗保健相关(HCA)或医院获得性(HA)。记录感染部位及细菌特征;评估对肝功能和30天生存率的影响。
420例肝硬化患者中有106例(25%)发生感染。住院患者感染率为37.5%(92/245),门诊患者感染率为8%(14/175)。106例患者中,CA、HCA和HA感染分别占19.8%、50%和30.2%。自发性细菌性腹膜炎(31.1%)、尿路感染(22.6%)以及肺炎和蜂窝织炎(各占11.3%)是常见感染。革兰阴性菌(54%)比革兰阳性球菌(46%)更常见。41.7%的患者存在多重耐药(MDR)菌。大多数MDR菌见于HCA和HA患者。感染患者的肝功能损害程度明显更严重。感染的独立预测因素是Child-Turcott-Pugh(CTP)分级高(p = 0.006,Child B级与A级相比(比值比(OR)3.04,95%可信区间[CI] = 1.63至5.68)以及Child C级与A级相比(OR 4.17,95% CI = 2.12至8.19)。总体住院死亡率为7.6%。与未感染患者相比,感染患者在30天随访时死亡率增加(23.5%对2.2%;p<0.001)。
感染是肝硬化患者发病和死亡的重要原因之一。最常见的感染是HCA和HA。感染易导致肝功能恶化并增加死亡率。应密切监测肝硬化患者的感染情况,尤其是Child B级和C级患者。